Acasti Pharma Inc (ACST)
2.70
-0.09
(-3.23%)
USD |
NASDAQ |
May 15, 16:00
2.68
-0.02
(-0.74%)
After-Hours: 20:00
Acasti Pharma Cash from Investing (Quarterly): -6.554M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.554M |
| September 30, 2023 | 0.11M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 4.992M |
| December 31, 2022 | -5.001M |
| September 30, 2022 | -0.096M |
| June 30, 2022 | 13.26M |
| March 31, 2022 | 0.011M |
| December 31, 2021 | 0.557M |
| September 30, 2021 | 2.837M |
| June 30, 2021 | -6.927M |
| March 31, 2021 | -8.417M |
| December 31, 2020 | -1.372M |
| September 30, 2020 | -0.033M |
| June 30, 2020 | -0.036M |
| March 31, 2020 | -0.399M |
| December 31, 2019 | -0.347M |
| September 30, 2019 | 3.366M |
| June 30, 2019 | 5.518M |
| March 31, 2019 | 3.248M |
| December 31, 2018 | -12.33M |
| September 30, 2018 | -0.1538M |
| June 30, 2018 | -0.2053M |
| March 31, 2018 | -0.0892M |
| December 31, 2017 | -0.1025M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0643M |
| June 30, 2017 | -0.0623M |
| November 30, 2016 | 0.4378M |
| August 31, 2016 | 1.831M |
| May 31, 2016 | 0.3956M |
| February 29, 2016 | -0.0898M |
| November 30, 2015 | 2.777M |
| August 31, 2015 | 2.675M |
| May 31, 2015 | 0.7106M |
| February 28, 2015 | 1.183M |
| November 30, 2014 | 3.484M |
| August 31, 2014 | 1.436M |
| May 31, 2014 | -0.0076M |
| February 28, 2014 | -20.07M |
| November 30, 2013 | 1.830M |
| August 31, 2013 | 0.2084M |
| May 31, 2013 | 0.5569M |
| February 28, 2013 | 0.1124M |
| November 30, 2012 | 0.2381M |
| August 31, 2012 | 1.261M |
| May 31, 2012 | 0.2429M |
| February 29, 2012 | 0.6146M |
| November 30, 2011 | -4.654M |
| August 31, 2011 | 0.5177M |
| May 31, 2011 | 0.5119M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.417M
Minimum
Mar 2021
13.26M
Maximum
Jun 2022
0.0772M
Average
-0.033M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | -6.257M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -0.057M |
| Xenon Pharmaceuticals Inc | -46.20M |
| ESSA Pharma Inc | 8.232M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.892M |
| Free Cash Flow | -13.57M |
| Free Cash Flow Per Share (Quarterly) | -0.0424 |
| Free Cash Flow Yield | -19.18% |